CLC Signs Agreement with Illumina for Next Generation Sequencing Analysis Technology.
CLC bio has entered into Illumina Connect partnership program with Illumina, Inc., to provide next generation sequencing analysis technology. Illumina Connect is a bioinformatics software partnership program established to advance data integration and analysis. As an Illumina Connect partner, CLC bio has access to information in the ongoing development of next generation sequencing tools.
